<DOC>
	<DOC>NCT02583399</DOC>
	<brief_summary>The primary objective of this study is to evaluate the pharmacokinetic profile of a single dose of intravenous ibuprofen administered over approximately ten (10) minutes.</brief_summary>
	<brief_title>Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients</brief_title>
	<detailed_description>The primary objective of this study is to evaluate the pharmacokinetic profile of a single dose of intravenous ibuprofen administered over approximately ten (10) minutes.</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Be a hospitalized male or female subject between birth (&gt; 37 weeks gestational age) and &lt; six (6) months of age. Have a clinical indication of pain or fever. Have written informed consent provided by legal parent, guardian, or authorized agent prior to participation in the study or performance of any studyonly related procedures. Have inadequate intravenous access. Have an uncorrected ductus dependent congenital heart disease. Have any history of allergy or hypersensitivity to nonsteroidal antiinflammatory drug or aspirin. Have a current history of uncorrected hypovolemia or acute renal disease. Have a current history of acute liver disease. Have received NSAID, acetaminophen, or aspirin drug therapy within four hours prior to dosing. Have received another investigational drug within the past 30 days. Be otherwise unsuitable for the study, in the opinion of the Investigator.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pediatric (Birth to less than 6 months of age)</keyword>
	<keyword>Pain</keyword>
	<keyword>Fever</keyword>
</DOC>